ECOA VIGILANCE
Live / Registered — Registered (as of 29 Sept 2026)
What this means for you
Registered since 29 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 99459202
- Registration number
- 8474046
- Mark type
- Word mark
- Filed
- 23 Oct 2025
- Published for opposition
- 12 May 2026
- Registered
- 29 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 29 Sept 2032 (grace period to 29 Mar 2033)
- Attorney of record
- Philip J. Cardinale
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for clinical trial administration; Software as a service (SAAS) services featuring software for medical data management; Software as a service (SAAS) services featuring software for patient compliance monitoring in clinical trials; Software as a service (SAAS) services featuring software for use in providing patient engagement in clinical trials
Owner
- Curebase, Inc., Fort Lauderdale, FL, US
- Curebase, Inc., Fort Lauderdale, FL, US
- Curebase, Inc., Fort Lauderdale, FL, US
Prosecution history
- 29 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Aug 2026 — USE AMENDMENT FILED
- 06 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2026 — PUBLISHED FOR OPPOSITION
- 06 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED